This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Ruprecht-Karls-Universitaet Heidelberg, Ruprecht-Karls-Universitat Heidelberg, Ruprecht-Karls-Universität. Active years: 2015-2020.
Company Filing History:
2 out of 23 
2 out of 64 
1 out of 7 Years Active: 2015-2020
Title: Biography of Inventor Miriam Reuschenbach
Introduction: Miriam Reuschenbach is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in the development of innovative vaccines.
Latest Patents: Miriam holds five patents, with her latest invention focusing on MSI-specific frameshift peptides (FSP) for the prevention and treatment of cancer. This vaccine is designed to target tumors characterized by microsatellite instability (MSI) and generates both humoral and cellular responses against tumor cells. It is particularly effective for the prevention and treatment of colorectal cancer, endometrial cancer, gastric cancer, and small bowel cancer.
Career Highlights: Throughout her career, Miriam has worked at Ruprecht-Karls-Universität Heidelberg, where she has been involved in groundbreaking research and development in the field of oncology. Her work has been instrumental in advancing the understanding and treatment of various cancers.
Collaborations: Miriam has collaborated with notable colleagues, including Matthias Kloor and Magnus Von Knebel-Doeberitz. These partnerships have enhanced her research efforts and contributed to the success of her innovative projects.
Conclusion: Miriam Reuschenbach is a trailblazer in cancer research, with a focus on developing effective vaccines. Her contributions to the field are invaluable, and her work continues to inspire future innovations in cancer treatment.